Long term outcomes still depend on lifestyle behaviors - - eating patterns, physical activity, adherence, coping strategies, and the ability to sustain changes over time
By application, type 2 diabetes dominates with over 52% share, followed by obesity with approximately 28%, while cardiovascular and cerebrovascular diseases contribute around 9%, NASH holds nearly 6%, and Alzheimers disease accounts for about 5% share
In preclinical research, BPC-157 accelerated the outgrowth and migration of tendon fibroblasts and improved their survival under oxidative stress, via the FAKpaxillin pathway[1]
With unprecedented investment flowing into this space, capturing the right patient populations has become critical